PATH stock $16.03 intraday (09 Jan 2026): 10% drop tests AI thesis

PATH stock $16.03 intraday (09 Jan 2026): 10% drop tests AI thesis

PATH stock fell to $16.03 intraday on 09 Jan 2026, a -10.15% move from the prior close on heavy volume. UiPath, Inc. (PATH) trades on the NYSE in the United States and is a core AI automation name that is reacting to mixed analyst notes and recent insider sales. We review the price action, key metrics—including PE 40.15 and market cap $9,017,363,898.00—and what this means for AI-focused portfolios.

PATH stock intraday move and drivers

UiPath (PATH) opened the session at $15.83 and hit a day high of $16.48 before retreating to $16.03.
The drop followed visible insider selling by CEO Daniel Dines and CFO Ashim Gupta and mixed analyst updates, which pressured sentiment.
Volume reached 20,021,900.00 shares vs average 30,748,103.00, showing elevated trading but below the heaviest days this year.

PATH stock technicals and valuation

Technicals show a neutral momentum setup: RSI 52.99 and MACD near 0.30, suggesting no clear trend.
Support lines include the Bollinger lower band at $15.19 and the 50-day average at $15.66; resistance sits near the Bollinger upper band at $18.30.
Valuation metrics show a trailing PE around 40.15, price/sales 5.80, and price/book 4.72, which place PATH above many software-infrastructure peers on multiples.

Earnings, growth and fundamentals

UiPath reported recent quarterly beats in revenue and EPS, with the firm showing revenue growth of 23.57% year-over-year in the latest full fiscal update.
Key fundamentals include EPS $0.42, revenue per share $2.88, and a healthy current ratio 2.54, which supports near-term liquidity.
Receivables days remain elevated at 116.59, a working-capital headwind to monitor for cash conversion.

Analyst consensus, insider activity and market reaction

Broker coverage skews neutral: consensus price target $15.80 and a median target $16.00, reflecting mixed views and a cluster of Hold ratings.
Recent filings show CEO Daniel Dines sold 45,000.00 shares at $17.32 and CFO Ashim Gupta sold 67,468.00 shares at $16.10, a factor weighing on short-term sentiment.
For details on filings and coverage, see the MarketBeat summary and Nasdaq quote page MarketBeat report and Nasdaq PATH page.

Meyka AI grade and model forecast

Meyka AI rates PATH with a score out of 100: 72.95 / B+ (BUY).
This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus.
Meyka AI’s forecast model projects a quarterly target of $18.51 and a yearly target of $15.03, compared with the current price $16.03. Forecasts are model-based projections and not guarantees.

Risk factors and a trading strategy for AI stocks

Key risks for PATH stock include valuation sensitivity, insider selling, and execution on AI product adoption within regulated industries.
A tactical approach: traders can watch $15.19 support and $18.30 resistance, use position sizing consistent with AI-stock volatility, and consider pairs or diversification inside the technology sector.
Long-term investors should weigh revenue growth vs high multiples and monitor next earnings and guidance updates.

Final Thoughts

Key takeaways for PATH stock: intraday weakness to $16.03 reflects short-term sentiment pressure from insider sales and mixed analyst notes, while fundamentals and growth metrics keep UiPath on AI watchlists. Meyka AI’s forecast model projects a quarterly target of $18.51, implying a 15.48% upside from $16.03, and a yearly target of $15.03, implying a -6.24% downside. Our B+ grade signals the model sees constructive medium-term fundamentals but elevated valuation risk. Traders should treat this as a market-data-driven setup: short-term traders can use the $15.19 support level and $18.30 resistance for entry and exits. Long-term investors focused on AI adoption should track upcoming guidance, the Needham conference presentation, and subsequent revenue growth metrics. Forecasts are model-based projections and not guarantees. For real-time tracking and our stock page, visit the Meyka PATH page for live updates and tools Meyka PATH page.

FAQs

What drove the PATH stock drop today?

PATH stock fell after visible insider selling by the CEO and CFO, mixed analyst notes and profit-taking. Higher trading volume of 20,021,900.00 shares amplified the move while valuation and sentiment reacted to coverage changes.

How is PATH stock valued versus peers?

PATH stock trades at a trailing PE near 40.15, price/sales 5.80, and price/book 4.72, which are above many software-infrastructure peers, reflecting expected growth but higher multiple risk.

What does Meyka AI forecast for PATH stock?

Meyka AI’s forecast model projects a quarterly price of $18.51 and a yearly price of $15.03. The quarterly target implies 15.48% upside from $16.03. Forecasts are projections, not guarantees.

Should investors buy PATH stock after the drop?

Decisions depend on risk tolerance. PATH stock shows growth metrics and a B+ Meyka grade, but insider sales and high multiples increase short-term risk. Consider position sizing, support at $15.19, and upcoming earnings when deciding.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *